Deutsche Bank Ag\ Vanda Pharmaceuticals Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 45,377 shares of VNDA stock, worth $208,734. This represents 0.0% of its overall portfolio holdings.

Number of Shares

45,377

Previous 34,671 30.88%

Holding current value

$208,734

Previous $195,000 8.72%

% of portfolio

0.0%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$4.61 - $6.34 $49,354 - $67,876	10,706 Added 30.88%	45,377 $212,000
Q2 2024 Aug 14, 2024	SELL	$3.91 - $6.5 $2,353 - $3,913	-602 Reduced 1.71%	34,671 $195,000
Q1 2024 May 15, 2024	BUY	$3.47 - $4.61 $9,271 - $12,317	2,672 Added 8.2%	35,273 $144,000
Q4 2023 Feb 14, 2024	SELL	$3.38 - $4.58 $24,167 - $32,747	-7,150 Reduced 17.99%	32,601 $137,000
Q3 2023 Nov 09, 2023	BUY	$4.28 - $6.57 $25,346 - $38,907	5,922 Added 17.51%	39,751 $171,000
Q2 2023 Aug 14, 2023	SELL	$5.9 - $6.95 $43,978 - $51,805	-7,454 Reduced 18.06%	33,829 $222,000
Q1 2023 May 15, 2023	SELL	$6.18 - $7.99 $27,408 - $35,435	-4,435 Reduced 9.7%	41,283 $280,000
Q4 2022 Feb 13, 2023	BUY	$6.87 - $10.96 $44,077 - $70,319	6,416 Added 16.32%	45,718 $337,000
Q3 2022 Nov 14, 2022	SELL	$9.44 - $11.76 $74,113 - $92,327	-7,851 Reduced 16.65%	39,302 $388,000
Q2 2022 Aug 11, 2022	SELL	$9.31 - $11.84 $66,259 - $84,265	-7,117 Reduced 13.11%	47,153 $515,000
Q1 2022 May 13, 2022	SELL	$10.84 - $16.55 $42,742 - $65,256	-3,943 Reduced 6.77%	54,270 $614,000
Q4 2021 Feb 11, 2022	SELL	$15.69 - $21.14 $46,144 - $62,172	-2,941 Reduced 4.81%	58,213 $914,000
Q3 2021 Nov 04, 2021	SELL	$15.35 - $21.27 $1.36 Million - $1.88 Million	-88,336 Reduced 59.09%	61,154 $1.05 Million
Q2 2021 Aug 11, 2021	SELL	$15.71 - $21.51 $90,882 - $124,435	-5,785 Reduced 3.73%	149,490 $3.22 Million
Q1 2021 May 13, 2021	BUY	$13.42 - $20.28 $1.2 Million - $1.81 Million	89,059 Added 134.5%	155,275 $2.33 Million
Q4 2020 Feb 16, 2021	BUY	$9.77 - $13.81 $154,815 - $218,833	15,846 Added 31.46%	66,216 $870,000
Q3 2020 Nov 12, 2020	SELL	$9.32 - $12.02 $397,386 - $512,508	-42,638 Reduced 45.84%	50,370 $486,000
Q2 2020 Aug 13, 2020	SELL	$9.66 - $12.02 $3.57 Million - $4.44 Million	-369,337 Reduced 79.88%	93,008 $1.06 Million
Q1 2020 May 14, 2020	BUY	$7.5 - $16.8 $3.32 Million - $7.44 Million	442,660 Added 2248.72%	462,345 $4.79 Million
Q4 2019 Feb 14, 2020	SELL	$12.38 - $17.47 $725,579 - $1.02 Million	-58,609 Reduced 74.86%	19,685 $322,000
Q3 2019 Nov 14, 2019	SELL	$12.27 - $15.79 $7.92 Million - $10.2 Million	-645,492 Reduced 89.18%	78,294 $1.04 Million
Q2 2019 Aug 14, 2019	BUY	$13.37 - $18.85 $7.96 Million - $11.2 Million	595,055 Added 462.25%	723,786 $10.2 Million
Q1 2019 May 15, 2019	SELL	$17.59 - $31.05 $185,433 - $327,329	-10,542 Reduced 7.57%	128,731 $2.37 Million
Q4 2018 Feb 14, 2019	SELL	$18.97 - $31.47 $3.49 Million - $5.79 Million	-183,962 Reduced 56.91%	139,273 $3.64 Million
Q3 2018 Dec 21, 2021	BUY	$18.25 - $23.0 $1.91 Million - $2.41 Million	104,689 Added 47.9%	323,235 $7.42 Million
Q3 2018 Nov 14, 2018	BUY	$18.25 - $23.0 $1.52 Million - $1.92 Million	83,483 Added 61.81%	218,546 $5.01 Million
Q2 2018 Apr 21, 2020	BUY	$13.95 - $19.15 $357,873 - $491,274	25,654 Added 23.45%	135,063 $2.57 Million
Q2 2018 Aug 14, 2018	BUY	$13.95 - $19.15 $679,797 - $933,198	48,731 Added 80.31%	109,409 $2.08 Million
Q1 2018 Oct 18, 2019	BUY	$14.05 - $20.2 $142,143 - $204,363	10,117 Added 20.01%	60,678 $1.02 Million
Q1 2018 May 15, 2018	SELL	$14.05 - $20.2 $873,221 - $1.26 Million	-62,151 Reduced 55.14%	50,561 $850,000
Q4 2017 Feb 14, 2018	SELL	$12.85 - $18.1 $1.17 Million - $1.65 Million	-91,105 Reduced 44.7%	112,712 $1.71 Million
Q3 2017 Nov 14, 2017	BUY	$15.4 - $18.85 $3.14 Million - $3.84 Million	203,817	203,817 $3.65 Million

Others Institutions Holding VNDA

# of Institutions

159

Shares Held

45.2M

Call Options Held

165K

Put Options Held

33.6K

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $260M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account